Agnes Jumar
Friedrich-Alexander-Universität Erlangen-Nürnberg(DE)Universitätsklinikum Erlangen(DE)
Publications by Year
Research Areas
Retinal Imaging and Analysis, Retinal Diseases and Treatments, Diabetes Treatment and Management, Blood Pressure and Hypertension Studies, Retinal and Optic Conditions
Most-Cited Works
- → Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus(2017)176 cited
- → A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation(2017)146 cited
- → Cocoa Flavanol Cardiovascular Effects Beyond Blood Pressure Reduction(2015)35 cited
- → Retinal Capillary Rarefaction in Patients with Type 2 Diabetes Mellitus(2016)25 cited
- → Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients(2016)21 cited
- → Effects of folic acid on renal endothelial function in patients with diabetic nephropathy: results from a randomized trial(2014)18 cited
- → Effect of aliskiren on vascular remodelling in small retinal circulation(2015)16 cited
- → Early Signs of End‐Organ Damage in Retinal Arterioles in Patients with Type 2 Diabetes Compared to Hypertensive Patients(2016)14 cited
- → Quality of life and emotional impact of a fixed‐dose combination of antihypertensive drugs in patients with uncontrolled hypertension(2016)12 cited
- → OS 12-03 SGLT-2-INHIBITION WITH DAPAGLIFLOZIN REDUCES TISSUE SODIUM CONTENT(2016)10 cited